Chirantan Chatterjee

Latest Institution: University of Utah

All Institutions: University of Utah; Georgia Institute of Technology; Sussex Business School, University of Sussex; Max Planck Institute for Innovation and Competition; Indian Institute of Management Ahmedabad


Causal Claims Network Graph

Edges that are evidenced by causal inference methods are in orange, and the rest are in light blue.

Based on the Following Papers:

Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry

Year: 2011
Journal: RAND Journal of Economics
Authors: Lee G. Branstetter; Chirantan Chatterjee; Matthew Higgins

Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation

Year: 2014
Journal: Research Policy
Authors: Lee Branstetter; Chirantan Chatterjee; Matthew J. Higgins

Unpacking the Effects of Adverse Regulatory Events: Evidence from Pharmaceutical Relabeling

Year: 2018
Journal: Research Policy
Authors: Matthew J. Higgins; Xin Yan; Chirantan Chatterjee

Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms

Year: 2018
Journal: No Journal Matched
Authors: Yujin Kim; Chirantan Chatterjee; Matthew J. Higgins

Can Greater Access to Education Be Inequitable? New Evidence from India's Right to Education Act

Year: 2020
Journal: No Journal Matched
Authors: Chirantan Chatterjee; Eric A. Hanushek; Shreekanth Mahendiran

Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak

Year: 2021
Journal: Research Policy
Authors: Mayank Aggarwal; Anindya Chakrabarti; Chirantan Chatterjee; Matthew J. Higgins


Author Disambiguation

This page includes results for all related names (only one name shown, no other authors with similar names):

Back to index